„On a Mission“ is not a movie,
but our attitude.
In the years of intensive talks and joint developments with top executives from the German health care sector, Kairos has gained an extraordinarily open look behind the scenes of the health care system. From the insight gained during this cooperation, it became evident that there was a need for a patient-centered system for treatment and research that existing hospital information systems did not satisfy. The core idea for such a system is a result of the reevaluation of biobanking.
While hospital information systems and the various available applications attempt to approach treatment using treatment control stations, they constantly reach the imminent borders of economic hospital management during the basic design of the system parameters. This means you are in constant danger of getting caught up in endless attempts to demonstrate verifiable expectations by health care providers and of losing the individual treatment of the single patient and his or her disease out of sight. In addition to this, by concentrating on the clinical and pre-clinical course of treatment, you risk excluding significant factors and persons involved in a comprehensive disease control. Medical, pharmaoncological, and biological research are often times not viewed as equal system parameters. The common laboratory and tissue sample information systems approach treatment from another direction. These systems create valuable knowledge for the treating doctor through effective sample handling and ideally through punctual documentation of the history of treatment.
Nonetheless, only a fraction of the knowledge-potential is taken advantage of, since a true dynamism and complete integration of other knowledge sources remains untouched. This means the chance is foregone to put biospecimens to use as sextants and statistically evaluable parameters for individualized treatment on a disease-map for pharmacological research.
Put in simple terms, there exist two information cycles in the health care system, which ideally overlap and complement each other. The active merging of these two cycles however is often left to the farsightedness of protagonists on site or to mere coincidence. An orchestrated wiring of these knowledge-systems is overdue, in order to achieve the desired quantum leap in treatment through “Personalized Medicine”.
Kairos will fill this gap with CentraXX and cause the formation of synapses in the German health care sector. The key to achieve this lies in the reevaluation of biobanking.
Occasionally one hears derogatory off-record comments regarding “Gammelfleisch” (rotten meat)-storage. This joke reveals a common misunderstanding and intellectual “short-circuit” in the German health care system, which costs incredible sums of money, causes personal sorrow, and makes the daily work in disease control more difficult. Kairos will cure this by introducing CentraXX and branding a Next Generation of Biobanking. Tissue- and blood sample data will become an integral and dynamic part of the knowledge networking in the health care sector as well as a central anchor of Personalized Medicine.